MEGAHENZ 160

Megahenz-160 Tablet is utilized as a symptomatic treatment for individuals diagnosed with breast cancer and endometrial cancer.

Breast cancer originates in the cells of the breast and is marked by the presence of a lump in the breast, alterations in the shape of the nipple or breast, and bloody discharge from the nipples. Endometrial cancer refers to cancer affecting the lining of the uterus, characterized by pelvic pain, intermenstrual bleeding, and discomfort during sexual intercourse.

The active ingredient in Megahenz-160 Tablet is ‘Megestrol’, which falls under the category of ‘Progestogens’. It functions similarly to the female hormone ‘progesterone’. This medication disrupts the production or action of hormones that contribute to cancer growth. Consequently, it aids in slowing the advancement of cancer and alleviating associated symptoms.

It is essential to take this medication precisely as prescribed by your healthcare provider. Common side effects of Megahenz-160 Tablet include increased appetite, weight gain, shortness of breath, hot flashes (redness of the face and neck), elevated blood pressure, heightened blood sugar levels, a rounded face, constipation, and swelling of a vein due to a blood clot. Should any of these side effects persist or worsen, please notify your doctor without delay.

Avoid taking Megahenz-160 Tablet if you are allergic to Megestrol or any of its components. Prior to using Megahenz-160 Tablet, inform your physician if you have severe liver issues, a history of thrombophlebitis (blood clots), stroke, adrenal gland disorders, or diabetes. Caution is advised when administering Megahenz-160 Tablet to elderly patients. This medication is not recommended for children, pregnant women, or nursing mothers. Additionally, refrain from consuming alcohol, as it may heighten the risk of side effects. Megahenz-160 Tablet is unlikely to impair your ability to drive.